Thromboembolic complications of sepsis: What is the incidence and pathophysiological mechanisms involved?

Michal Holub

doi:10.1160/TH08-03-0192

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2008; 99(05): 801-802
DOI: 10.1160/TH08-03-0192

Editorial Focus

Schattauer GmbH

Thromboembolic complications of sepsis: What is the incidence and pathophysiological mechanisms involved?

Authors

Michal Holub

¹3rd Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University in Prague, Czech Republic

Abstract

Full Text

References

References
1 Levine R, LeClerc J, Bailey J. et al. Venous and arterial thromboembolism in severe sepsis. Thromb Haemost 2008; 99: 892-898.
2 Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1981; 10: 448-450.
3 Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. J Am Med Assoc 1995; 274: 335-337.
4 Samama MM, Cohen AT, Darmon JY. et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
5 Bernard GR, Vincent JL, Laterre PF. et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
6 Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41.
7 Zenahlikova Z, Vyborny J, Uchytil Z. et al. Thromboembolic complications of sepsis and their pharmacological prophylaxis. Cas Lek Ces 2007; 146: 597-602.
8 Dellinger RP, Carlet JM, Masur H. et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30: 536-555.
9 Geerts WH, Pineo GF, Heit JA. et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl. 03) 338S-400S.
10 Rutherford EJ, Schooler WG, Sredzienski E. et al. Optimal dose of enoxaparin in critically ill trauma and surgical patiens. J Trauma 2005; 58: 1167-1170.
11 Hamm CW, Giannitis E. Katus EI et al. Cardiac troponin elevation in patiens without acute coronary syndrome. Circulation 2002; 106: 2871-2872.
12 Gurkan F, Alkaya A, Ece A. et al. Cardiac troponin-I as a marker of myocardial dysfunction in children with septic shock. Weiss Med Wkly 2004; 134: 593-596.
13 Sharshar T, Carlier R, Bernard F. et al. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med 2007; 33: 798-806.